Ibogaine treatment not a cure-all, expert warns after Gerber's death

Ibogaine treatment not a miracle cure, expert warns

Following the death of Presley Gerber, an advocate for ibogaine treatment has highlighted the complexities of using the psychoactive drug for addiction. Bryan Hubbard, CEO of Americans for Ibogaine, discussed the drug's potential and limitations on "TMZ Live" after Gerber's recent passing.

What the expert says

Hubbard explained that ibogaine is known for its ability to "rewrite neural pathways," offering individuals battling addiction a chance to combat their dependencies. However, he cautioned that ibogaine should not be viewed as a "magic pill" or a definitive cure. Instead, it provides a temporary "neurochemical restoration," which can help reduce withdrawal symptoms and offer a window for making better decisions in the future.

Circumstances of Gerber's death

Presley Gerber, who had been open about his struggles with addiction, died in a rehab facility. While the exact cause of death remains under investigation, authorities are considering an overdose as a possibility. Dispatch audio indicated that Gerber suffered cardiac arrest before his death, though the official cause has been deferred pending further investigation.

Why it matters

The discussion around ibogaine is significant as it underscores the need for a nuanced understanding of addiction treatments. While ibogaine shows promise in aiding recovery, it is not without risks. Gerber's case highlights the importance of thorough research and careful consideration when using such treatments.

Hubbard's insights serve as a reminder that while ibogaine can be a valuable tool in addiction recovery, it is not a standalone solution. Continued investigation and understanding are crucial for improving outcomes for those struggling with addiction.